CHA News Article

FDA Announces Dozens More Drug Shortages in 2017 Than 2016

A new annual report from the Food and Drug Administration (FDA) highlights 39 drug and biological product shortages that began in 2017, up from 26 new shortages in 2016. The increase is partially due to disruptions caused in the fall of 2017 by Hurricanes Harvey, Irma and Maria. According to the report, federal actions have resulted in manufacturers notifying the FDA of shortages earlier than in previous years, allowing the agency additional time to work with stakeholders to maintain treatment options and prevent shortages. However, FDA notes that drug shortages continue to pose a significant public health threat. 

The report also notes 41 ongoing shortages from previous years. FDA says it will “continue to prioritize this important public health issue, working to ensure the availability of necessary drugs and biological products for the American public.”